Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954)

This publication has 17 references indexed in Scilit:

• Separation of a subunit necessary for CDP reductase from other ribonucleotide reductase activities of regenerating rat liver
  Biochemical and Biophysical Research Communications, 1979
• Studies on the protection by imidazoles against the cytotoxicity of the antitumour alkylating agents melphalan and CB 1954
  Biochemical Pharmacology, 1976
• Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds
  Biochemical Pharmacology, 1975
• Studies on the reversal of the selective antitumour effect of the aziridinyl derivative cb 1954 by 4‐amino‐5‐imidazolecarboxamide
  International Journal of Cancer, 1972
• The differential response of resistant and sensitive strains of Escherichia coli to the cytotoxic effects of 5-aziridino-2,4-dinitrobenzamide (CB 1954)
  Chemico-Biological Interactions, 1971
• Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the walker tumour
  International Journal of Cancer, 1971
• Synchronized mammalian cell cultures: III. Variation of ribonucleotide reductase activity during the replication cycle of Chinese hamster fibroblasts
  Experimental Cell Research, 1969
• 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256
  Biochemical Pharmacology, 1969
• Effect of hydroxyurea on ribonucleotide reductase
  Biochemical and Biophysical Research Communications, 1968
• Effects upon tumours of Various Haloalkylarylamines
  Nature, 1948